Researchers Dissect the Influenza Virus
Posted on: Thursday, 26 January 2006, 15:00 CST
University of Wisconsin-Madison scientists say how the influenza virus organizes its genetic contents is selective and not random, as previously thought.
The researchers said their discovery might speed the development of antiviral drugs and vaccines, as well as the harnessing of benign influenza viruses as gene vectors to optimize vaccine protection.
We've found that the influenza virus has a specific mechanism that permits it to package its genetic materials as it creates its infectious particles, said Yoshihiro Kawaoka, a professor at both the University of Wisconsin's School of Veterinary Medicine and the University of Tokyo. He and a team of researchers from Japan, Sweden and California conducted the study using an electron microscope and a technique known as electron tomography.
Kawaoka said the findings might prove vital as the world's health officials deal with the possibility of an avian flu pandemic.
The research is detailed in the journal Nature.
Source: United Press International
Related Articles
- Universal Influenza Vaccination Could Reduce Antibiotic Use
- VaxInnate to Present Positive Results From Clinical Trial of Universal Flu Vaccine Candidate at ICAAC/IDSA Meeting
- VaxInnate Reports Positive Results From Phase I Influenza Vaccine Study
- VaxInnate's M2e Universal Influenza Vaccine Candidate Demonstrates Safety and Immunogenicity in Phase I Clinical Study
- Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine
- Inovio Biomedical's First Proprietary DNA Vaccine Achieves 100% Protection Against Avian Flu in Pre-Clinical Testing
- VaxInnate Initiates Phase I Clinical Study of M2e Universal Influenza Vaccine
- Dynavax Secures $3 Million Flu Vaccine Grant
- Acambis Influenza Vaccine Enters Phase I
- Belgian Researcher Developing Universal Influenza Vaccine
 |
 |
User Comments (0)
RSS Feeds